» Articles » PMID: 29941717

Research Progress in the Pathogenesis of Alzheimer's Disease

Overview
Specialty General Medicine
Date 2018 Jun 27
PMID 29941717
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Alzheimer's disease (AD) is a kind of chronic degenerative disease of the central nervous system, characteristics of cognitive dysfunction, and behavioral disability. The pathological changes include the formation of senile plaques-containing beta-amyloid (Aβ), neurofibrillary tangles (NFTs), loss of neurons, and synapses. So far, the pathogenesis of AD is still unclear. This study was aimed to review the major pathogenesis of AD-related to the published AD studies in recent 20 years.

Data Sources: The author retrieved information from the PubMed database up to January 2018, using various search terms and their combinations, including AD, Aβ, NFTs, pathogenesis, and genetic mutation.

Study Selection: The author included data from peer-reviewed journals printed in English and Chinese on pathophysiological factors in AD. He organized these informations to explain the possible pathogenesis in AD.

Results: There are many amounts of data supporting the view that AD pathogenesis so far there mainly are Aβ toxicity, tau protein, gene mutation, synaptic damages, intermediate neurons and network abnormalities, changes in mitochondrial function, chemokines, etc., Its nosogenesis may be involved in multiple theories and involved in multiple molecular signaling pathways, including Aβ, tau protein, and synaptic anomaly; mutual relationship between the mechanisms urge jointly neuronal degeneration.

Conclusions: This review highlights the research advances in the pathogenesis of AD. Future research has needed to fully disclose the association between multiple pathogenesis at the same time to interdict multiple signaling pathways, etc.

Citing Articles

Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors.

Bindra S, Mostafa E, Abdelgawad M, Selim S, Kumar S, Mathew B RSC Med Chem. 2025; .

PMID: 39925735 PMC: 11799932. DOI: 10.1039/d4md00837e.


Perception and attitude of the general population toward Alzheimer's disease in eastern region, Saudi Arabia.

Alradi H, Alturaiki H, Alali M, Almuslim N J Family Med Prim Care. 2025; 13(12):5752-5757.

PMID: 39790785 PMC: 11709029. DOI: 10.4103/jfmpc.jfmpc_1019_24.


Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease.

Vahid Z, Eskandani M, Dadashi H, Vandghanooni S, Rashidi M Heliyon. 2024; 10(23):e40756.

PMID: 39717593 PMC: 11664286. DOI: 10.1016/j.heliyon.2024.e40756.


Exploring the protective effect and molecular mechanism of betulin in Alzheimer's disease based on network pharmacology, molecular docking and experimental validation.

Wang N, Cui J, Sun Z, Chen F, He X Mol Med Rep. 2024; 30(6).

PMID: 39392030 PMC: 11529172. DOI: 10.3892/mmr.2024.13356.


Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer's Disease.

Wang Y, Song X, Wang R, Xu X, Du Y, Chen G J Alzheimers Dis Rep. 2024; 8(1):1185-1197.

PMID: 39247875 PMC: 11380310. DOI: 10.3233/ADR-240062.


References
1.
Sollvander S, Nikitidou E, Brolin R, Soderberg L, Sehlin D, Lannfelt L . Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Mol Neurodegener. 2016; 11(1):38. PMC: 4865996. DOI: 10.1186/s13024-016-0098-z. View

2.
Daschil N, Obermair G, Flucher B, Stefanova N, Hutter-Paier B, Windisch M . CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model. J Alzheimers Dis. 2013; 37(2):439-51. PMC: 4312770. DOI: 10.3233/JAD-130560. View

3.
Poorkaj P, Kas A, DSouza I, Zhou Y, Pham Q, Stone M . A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm Genome. 2001; 12(9):700-12. DOI: 10.1007/s00335-001-2044-8. View

4.
Dolan P, Johnson G . A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol Chem. 2010; 285(29):21978-87. PMC: 2903354. DOI: 10.1074/jbc.M110.110940. View

5.
Nixon R . Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007; 120(Pt 23):4081-91. DOI: 10.1242/jcs.019265. View